Orchard’s Lenmeldy won FDA approval, with the price tag of $4.25 million, the therapy quickly took the title of most expensive drug

FDAs Peter Marks, M.D., Ph.D., receives a simple email from Commissioner Robert Califf, M.D. each time a gene therapy gets approved.

What the Hell, it’s Only $4.25 million for a single patient!

Fierce Pharma spreads the ‘exciting’ news once again:

For every million-dollar gene therapy, Peter Marks gets an email from FDA chief Robert Califf

After Orchard Therapeutics’ gene therapy for a rare genetic disease was approved in March, Peter Marks, M.D., Ph.D., received a simple email from Com…